Extensions — US Patent 7571014

Patent Term: The term for a US utility patent is 20 years from the earliest non-provisional filing date. For US Patent 7,571,014, the application (US 10/861,653) was filed on June 5, 2004. However, it claims priority as a continuation-in-part to an earlier application (US 10/816,217) filed on April 1, 2004. Therefore, the standard 20-year term would end on April 1, 2024.
Patent Term Adjustment (PTA): The USPTO may grant Patent Term Adjustments to compensate for certain administrative delays during the patent's prosecution. According to the provided patent data, US Patent 7,571,014 has an adjusted expiration date. No specific number of PTA days is listed in the provided documentation. A Patent Term Extension (PTE) is distinct from PTA and is typically granted for delays in FDA regulatory review for pharmaceutical products, which is not applicable here.
Projected Expiration Date: The projected expiration date for US Patent 7,571,014 is March 28, 2027. This date includes any granted Patent Term Adjustments.

Continuation-in-Part: The application for this patent, US 10/861,653, is a continuation-in-part of US application Ser. No. 10/816,217, filed on April 1, 2004. That parent application subsequently issued as US Patent 8,234,395.
Related Family Members: This patent is part of a large family of patents and applications that claim priority to the same original application. Numerous subsequent applications claim priority back to this patent's family tree. Notable issued patents in this family, as listed in the provided documentation, include: